Literature DB >> 8903323

Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts.

Z K Pan1, B L Zuraw, C C Lung, E R Prossnitz, D D Browning, R D Ye.   

Abstract

Bradykinin (BK), a pluripotent nonameric peptide, is known for its proinflammatory functions in both tissue injury and allergic inflammation of the airway mucosa and submucosa. To understand the mechanisms by which BK serves as an inflammatory mediator, the human lung fibroblast cell line WI-38 was stimulated with BK and the expression of IL-1beta gene was examined. BK at nanomolar concentrations induced a marked increase in immunoreactive IL-1beta, detectable within 2 h in both secreted and cell-associated forms. BK-induced IL-1beta synthesis was inhibited by a B2-type BK receptor antagonist and by treatment of the cells with pertussis toxin, indicating the involvement of a BK receptor that couples to the G(i)/G(o) class of heterotrimeric G proteins. Whereas cycloheximide and actinomycin D both inhibited BK-induced IL-1beta synthesis, results from Northern blot and nuclear run-on assays suggested that BK acted primarily at the transcription level which led to the accumulation of IL-1beta message in stimulated cells. Gel mobility shift assays were used with nuclear extracts from stimulated WI-38 cells to examine the transcription mechanism for BK-induced IL-1beta expression. A DNA binding activity specific for the decameric kappaB enhancer was detected and was found to contain the p50 and p65 subunits of the NF-kappaB/rel protein family. BK-induced NF-kappaB activation correlated with IL-1beta message upregulation with respect to agonist concentration, time course, sensitivity to bacterial toxins, and blockade by the B2 receptor antagonist. After BK stimulation, a significant increase in the activity of chloramphenicol acetyltransferase was observed in WI-38 cells transfected with a reporter plasmid bearing the kappaB enhancers from the IL-1beta gene. Deletion of the kappaB enhancer sequence significantly reduced BK-induced chloramphenicol acetyltransferase activity. These findings suggests a novel function of BK in the activation of NF-kappaB and the induction of cytokine gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903323      PMCID: PMC507648          DOI: 10.1172/JCI119009

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  B2 bradykinin receptors in NG108-15 cells: cDNA cloning and functional expression.

Authors:  S Yokoyama; Y Kimura; M Taketo; J A Black; B R Ransom; H Higashida
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

2.  Autoregulation of I kappa B alpha activity.

Authors:  P J Chiao; S Miyamoto; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

3.  The G protein G13 mediates inhibition of voltage-dependent calcium current by bradykinin.

Authors:  M A Wilk-Blaszczak; W D Singer; S Gutowski; P C Sternweis; F Belardetti
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

4.  IL-1 beta amplifies bradykinin-induced prostaglandin E2 production via a phospholipase D-linked mechanism.

Authors:  J Angel; F Audubert; G Bismuth; C Fournier
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

5.  Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes. Correlation with an increased kappa B binding activity.

Authors:  Z Pan; V V Kravchenko; R D Ye
Journal:  J Biol Chem       Date:  1995-04-07       Impact factor: 5.157

6.  NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site.

Authors:  J P Cogswell; M M Godlevski; G B Wisely; W C Clay; L M Leesnitzer; J P Ways; J G Gray
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

7.  Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation.

Authors:  T Nakajima; I Kitajima; H Shin; I Takasaki; K Shigeta; K Abeyama; Y Yamashita; T Tokioka; Y Soejima; I Maruyama
Journal:  Biochem Biophys Res Commun       Date:  1994-10-28       Impact factor: 3.575

8.  Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production.

Authors:  B Mari; V Imbert; N Belhacene; D F Far; J F Peyron; J Pouysségur; E Van Obberghen-Schilling; B Rossi; P Auberger
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

9.  Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway.

Authors:  V V Kravchenko; Z Pan; J Han; J M Herbert; R J Ulevitch; R D Ye
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

10.  Expression cloning of a human B1 bradykinin receptor.

Authors:  J G Menke; J A Borkowski; K K Bierilo; T MacNeil; A W Derrick; K A Schneck; R W Ransom; C D Strader; D L Linemeyer; J F Hess
Journal:  J Biol Chem       Date:  1994-08-26       Impact factor: 5.157

View more
  26 in total

1.  Synergistic activation of NF-{kappa}B by bacterial chemoattractant and TNF{alpha} is mediated by p38 MAPK-dependent RelA acetylation.

Authors:  Warren W Pan; Jain-Dong Li; Shuang Huang; Thomas J Papadimos; Zhixing K Pan; Ling-Yu Chen
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema.

Authors:  Francesco Arcoleo; Mariangela Lo Pizzo; Gabriella Misiano; Salvatore Milano; Giuseppina Colonna Romano; Vito Muggeo; Enrico Cillari
Journal:  Clin Exp Med       Date:  2018-04-06       Impact factor: 3.984

3.  Bradykinin stimulates interleukin-8 production by human lung fibroblasts.

Authors:  R Hayashi; N Yamashita; S Matsui; M Maruyama; E Sugiyama; S Sugiyama; M Kobayashi
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

4.  Factors Modifying the Risk of Atrial Fibrillation Associated With Atrial Premature Complexes in Patients With Hypertension.

Authors:  Elsayed Z Soliman; George Howard; Suzanne Judd; Prashant D Bhave; Virginia J Howard; David M Herrington
Journal:  Am J Cardiol       Date:  2020-02-08       Impact factor: 2.778

5.  Identification of a nuclear localization sequence in β-arrestin-1 and its functional implications.

Authors:  Crystal Zoe Hoeppner; Ni Cheng; Richard D Ye
Journal:  J Biol Chem       Date:  2012-01-21       Impact factor: 5.157

6.  The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.

Authors:  J P Schanstra; E Bataillé; M E Marin Castaño; Y Barascud; C Hirtz; J B Pesquero; C Pecher; F Gauthier; J P Girolami; J L Bascands
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

Review 7.  HAE Pathophysiology and Underlying Mechanisms.

Authors:  Bruce L Zuraw; Sandra C Christiansen
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

8.  PKC- and ERK-dependent activation of I kappa B kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor-mediated CaMK activation.

Authors:  B C Chen; W W Lin
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

9.  Kinin B1 receptors contributes to acute pain following minor surgery in humans.

Authors:  May Hamza; Xiao-Min Wang; Albert Adam; Jaime S Brahim; Janet S Rowan; Gilberto N Carmona; Raymond A Dionne
Journal:  Mol Pain       Date:  2010-02-13       Impact factor: 3.395

10.  Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa.

Authors:  Hideaki Shirasaki; Etsuko Kanaizumi; Tetsuo Himi
Journal:  Mediators Inflamm       Date:  2009-04-23       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.